New 20-Strain pneumonia vaccine shows promise for infants
NCT ID NCT05512819
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new vaccine (20vPnC) that protects against 20 types of pneumococcal bacteria, which can cause pneumonia and meningitis. Over 500 healthy infants in India and Taiwan received either the new vaccine or an existing one (13vPnC) as a series of four shots. Researchers monitored safety and immune responses for about 15 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
20-valent pneumococcal conjugate vaccine
What this could lead to
If successful, this vaccine could protect infants against 20 types of pneumococcal bacteria, reducing serious illnesses like pneumonia and meningitis.
What could go wrong
This is a completed Phase 3 trial, but results are not yet published. The vaccine may cause side effects like fever or swelling, and its long-term effectiveness is still being studied.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PNEUMOCOCCAL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
BGS Global Institute of Medical Sciences (BGSGIMS)
Bangalore, Karnataka, 560060, India
-
Bharati Vidyapeeth {Deemed to be University) Medical College Hospital & Research Centre
Pune, Maharashtra, 411043, India
-
Chang Gung Medical Foundation-Linkou Branch
Taoyuan, 333, Taiwan
-
Hsinchu Mackay Memorial Hospital
Hsinchu, Hsinchu, 30071, Taiwan
-
Institute of Child Health
Kolkata, West Bengal, 700017, India
-
Jawahar Lal Nehru Medical College
Ajmer, Rajasthan, 305001, India
-
Mackay Memorial Hospital
Taipei, 10449, Taiwan
-
Maulana Azad Medical College and Associated with Lok Nayak Hospital
New Delhi, National Capital Territory of Delhi, 110002, India
-
National Taiwan University Hospital
Taipei, 10002, Taiwan
-
Nirmal Hospital Pvt Ltd.
Surat, Gujarat, 395002, India
-
Taichung Veterans General Hospital
Taichung, 407219, Taiwan